Helmut Winffel

Helmut Winffel serves as a key procurement lead within the National Heart, Lung, and Blood Institute (NHLBI), supporting the agency’s mission to advance biomedical research through strategic acquisitions of analytical laboratory instrumentation, specialized research services, and biologic data infrastructure. He manages a diverse portfolio of contracts focused on high-precision scientific equipment, biotechnology R&D, and technical support services critical to precision medicine and single-cell genomics initiatives. His work ensures NHLBI’s research ecosystem remains equipped with cutting-edge capabilities to drive discovery in cardiovascular, pulmonary, and hematologic disorders. Winffel maintains longstanding partnerships with leading academic medical centers, including the University of Mississippi Medical Center and Wake Forest University Health Sciences, as well as specialized research firms such as TDA Research, Inc. These relationships reflect a preference for institutions with demonstrated expertise in translational science and laboratory automation. His contracting patterns emphasize collaboration with organizations capable of delivering complex, compliance-driven solutions aligned with NIH research standards, often requiring stringent validation and regulatory alignment. His procurement approach is overwhelmingly non-set-aside, with 98.4% of awards issued under open competition, indicating a priority for technical capability over socioeconomic preferences. While small business set-asides represent only 1.6% of his portfolio, they are strategically deployed to support qualified vendors with niche technical expertise in instrumentation or biologic data systems. His primary NAICS focus lies in analytical laboratory instrument manufacturing (334516), followed by professional scientific services (541990) and biotechnology R&D (541714). He routinely procures next-generation sequencing platforms, flow cytometers, mass spectrometers, and associated data analysis infrastructure, demonstrating deep domain expertise in molecular diagnostics and high-throughput biological research systems. His contracting decisions reflect a rigorous alignment with NHLBI’s scientific priorities and technical requirements.